Skip to main content
. Author manuscript; available in PMC: 2019 Jun 1.
Published in final edited form as: J Neurosci Methods. 2018 Mar 31;303:30–40. doi: 10.1016/j.jneumeth.2018.03.006

Table 3. CSF, peripheral tissue and blood 125I levels 60 min following a single, one-time 125I-labled DNSP-11 dose.

125I signal was present in CSF, the thyroid gland, urine and blood samples as analyzed by gamma counter (Perkin-Elmer Cobra II Gamma Counter: Packard; preset energy range 15 to 74 KeV, 1 min runtime). Blood samples were taken from the saphenous vein in 15 min intervals following the start of the first intranasal dose (t=0). Data are presented as total 125I signal (CPM) and normalized 125I signal (CPM/mg). NHPs treated with vehicle only were found to have CPM values lower than background levels ≤ 50 cpm (data not shown).

Samples CPM (Counts Per Min) Normalized CPM/mg
CNS
CSF 2530 25
Peripheral Samples
Thyroid Gland 8181000 15480
Urine 1984500 19845
Blood Samples
15 min 77850 779
30 min 89160 892
45 min 96970 970
60 min 99700 997